FMEDvsIGSB
Fidelity Covington Trust - Disruptive Medicine ETF against iShares 1-5 Year Investment Grade Corporate Bond ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| FMED | IGSB | |
|---|---|---|
| Expense ratio | 0.50% | 0.040% |
| Assets | $55M | $23.4B |
| Net flow, 1 month | — | +$251M |
| Net flow, 1 year | — | +$2.6B |
| Return, YTD | +19.7% | -3.4% |
| Return, 1 year | +27.7% | -3.6% |
| Avg daily volume | 7K | 5M |
| Holdings | 63 | 3892 |
| Listed | Jun 12, 2023 | Jan 5, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS